<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The calcium-permeable transient receptor potential M2 (TRPM2) ion channel is activated following <z:mp ids='MP_0003674'>oxidative stress</z:mp> and has been implicated in ischemic damage; however, little experimental evidence exists linking TRPM2 channel activation to damage following <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We directly assessed the involvement of TRPM2 channels in ischemic brain injury using pharmacological inhibitors and short-hairpin <z:chebi fb="40" ids="33697">RNA</z:chebi> (shRNA)-mediated knockdown of TRPM2 expression </plain></SENT>
<SENT sid="2" pm="."><plain>Each of the four TRPM2 inhibitors tested provided significant protection to male neurons following in vitro <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation, OGD), while having no effect in female neurons </plain></SENT>
<SENT sid="3" pm="."><plain>Similarly, TRPM2 knockdown by TRPM2 shRNA resulted in significantly reduced neuronal cell <z:hpo ids='HP_0011420'>death</z:hpo> following OGD only in male neurons </plain></SENT>
<SENT sid="4" pm="."><plain>The TRPM2 inhibitor <z:chebi fb="1" ids="3764">clotrimazole</z:chebi> reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in male mice, while having no effect on female <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, intrastriatal injection of lentivirus expressing shRNA against TRPM2 resulted in significantly smaller striatal <z:mpath ids='MPATH_124'>infarcts</z:mpath> only in male mice following middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, having no significant effect in female mice </plain></SENT>
<SENT sid="6" pm="."><plain>Data presented in the current study demonstrate that TRPM2 inhibition and knockdown preferentially protects male neurons and brain against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in vitro and in vivo, indicating that TRPM2 inhibitors may provide a new therapeutic approach to the treatment of <z:hpo ids='HP_0001297'>stroke</z:hpo> in men </plain></SENT>
</text></document>